GQG Partners
JNJ icon

GQG Partners’s Johnson & Johnson JNJ Stock Holding History

GQG Partners’s Portfolio JNJ Stock Details JNJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.79B Sell
7,317,289
-434,977
-6% -$101M 2.84% 11
2025
Q4 		$1.6B Buy
7,752,266
+1,714,687
+28% +$339M 2.64% 13
2025
Q3 		$1.12B Buy
6,037,579
+5,988,242
+12,137% +$1.03B 1.72% 21
2025
Q2 		$7.54M Buy
49,337
+47,706
+2,925% +$7.33M 0.01% 68
2025
Q1 		$270K Sell
1,631
-4
-0.2% -$626 ﹤0.01% 82
2024
Q4 		$236K Sell
1,635
-1,501,005
-100% -$233M ﹤0.01% 92
2024
Q3 		$244M Buy
1,502,640
+1,446,772
+2,590% +$231M 0.38% 46
2024
Q2 		$8.17M Buy
+55,868
New +$8.31M 0.01% 51
2023
Q1 		– Sell
-51,523
Closed -$9.1M – 85
2022
Q4 		$9.1M Sell
51,523
-1,106,633
-96% -$191M 0.02% 58
2022
Q3 		$189M Sell
1,158,156
-5,411,568
-82% -$916M 0.55% 39
2022
Q2 		$1.17B Buy
6,569,724
+67,963
+1% +$12.1M 2.86% 14
2022
Q1 		$1.15B Buy
6,501,761
+2,547,378
+64% +$433M 2.67% 15
2021
Q4 		$676M Buy
3,954,383
+3,627,424
+1,109% +$594M 1.68% 21
2021
Q3 		$52.8M Buy
326,959
+320,422
+4,902% +$54.7M 0.14% 41
2021
Q2 		$1.08M Sell
6,537
-422,243
-98% -$69.9M ﹤0.01% 55
2021
Q1 		$70.5M Buy
428,780
+205,813
+92% +$33.3M 0.26% 46
2020
Q4 		$35.1M Buy
222,967
+212,249
+1,980% +$31.3M 0.12% 49
2020
Q3 		$1.59M Buy
10,718
+511
+5% +$75.6K 0.01% 60
2020
Q2 		$1.44M Buy
+10,207
New +$1.49M 0.01% 55
2018
Q3 		– Sell
-124,635
Closed -$13.1M – 53
2018
Q2 		$13.1M Buy
124,635
+121,464
+3,830% +$15.2M 0.31% 36
2018
Q1 		$406K Sell
3,171
-540,486
-99% -$73.1M 0.01% 48
2017
Q4 		$76M Buy
543,657
+20,825
+4% +$2.9M 2.39% 14
2017
Q3 		$68M Buy
522,832
+243,306
+87% +$32.3M 2.39% 16
2017
Q2 		$37M Buy
+279,526
New +$35.7M 2.72% 12
2017
Q1 		– Sell
-2,168
Closed -$250K – 50
2016
Q4 		$250K Buy
+2,168
New +$250K 0.17% 42

Other funds holding JNJ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

GQG Partners's JNJ Position: Q1 2026 in Review

GQG Partners reduced its Johnson & Johnson (JNJ) stake by 5.6% in Q1 2026, selling an estimated $101M and leaving 7,317,289 shares worth $1.79B. The position accounts for 2.84% of the portfolio, ranked #11.

GQG Partners first reported a position in JNJ in Q4 2016 and has held it in 25 quarters since. 4,619 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • GQG Partners held 7,317,289 shares of Johnson & Johnson worth $1.79B as of Q1 2026.
  • GQG Partners sold 434,977 Johnson & Johnson shares in Q1 2026, an estimated $101M.
  • Johnson & Johnson made up 2.84% of GQG Partners's portfolio in Q1 2026, its #11 holding.
  • GQG Partners first reported a position in Johnson & Johnson in Q4 2016 and has held it in 25 quarters since.
  • 4,619 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on GQG Partners's 13F filing for Q1 2026, filed 12 May 2026.